Dexamethasone has additive effect when combined with ondansetron and droperidol for treatment of established PONV

Acta Anaesthesiologica Scandinavica

Volumn 55, Issue 10, 2011, Pages 1196-1205

  Ormel, G ^a   Romundstad, L ^a,b   Lambert Jensen, P ^a   Stubhaug, A ^a,b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; DROPERIDOL; ONDANSETRON; PLACEBO;

ADULT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; GYNECOLOGIC SURGERY; HOSPITAL DISCHARGE; HUMAN; MAJOR CLINICAL STUDY; POSTOPERATIVE NAUSEA AND VOMITING; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADOLESCENT; ADULT; AGED; AMBULATORY SURGICAL PROCEDURES; ANTIEMETICS; DEXAMETHASONE; DROPERIDOL; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; METOCLOPRAMIDE; MIDDLE AGED; ONDANSETRON; PATIENT SATISFACTION; POSTOPERATIVE NAUSEA AND VOMITING; PROSPECTIVE STUDIES; RISK; YOUNG ADULT;

EID: 80054047359     PISSN: 00015172     EISSN: 13996576     Source Type: Journal    
DOI: 10.1111/j.1399-6576.2011.02536.x     Document Type: Article

References (29)

1. Sinclair DR, Chung F, Mezei G,. Can postoperative nausea and vomiting be predicted? Anesthesiology 1999; 91: 109-118. (Pubitemid 29307343)
2. Tramèr MR,. Strategies for postoperative nausea and vomiting. Best Pract Res Clin Anaesthesiol 2004; 18: 693-701. (Pubitemid 39145053)
3. White H, Black RJ, Jones M, Mar Fan GC,. Randomized comparison of two anti-emetic strategies in high-risk patients undergoing day-case gynaecological surgery. Br J Anaesth 2007; 98: 470-476. (Pubitemid 47072646)
4. Henzi I, Walder B, Tramèr MR,. Dexamethasone for the prevention of postoperative nausea and vomiting: a quantitative systematic review. Anesth Analg 2000; 90: 186-194. (Pubitemid 30022994)
5. Apfel CC, Korttila K, Abdalla M, Kerger H, Turan A, Vedder I, Zernak C, Danner K, Jokela R, Pocock SJ, Trenkler S, Kredel M, Biedler A, Sessler DI, Roewer N,. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med 2004; 350: 2441-2451.
6. Skledar SJ, Williams BA, Vallejo MC, Dalby PL, Waters JH, Glick R, Kentor ML,. Eliminating postoperative nausea and vomiting in outpatient surgery with multimodal strategies including low doses of nonsedating, off-patent antiemetics: is 'zero tolerance' achievable? ScientificWorldJournal 2007; 7: 959-977. (Pubitemid 46953950)
7. Kazemi-Kjellberg F, Henzi I, Tramèr MR,. Treatment of established postoperative nausea and vomiting: a quantitative systematic review. BMC Anesthesiol 2001; 1: 2.
8. Rüsch D, Arndt C, Martin H, Kranke P,. The addition of dexamethasone to dolasetron or haloperidol for treatment of established postoperative nausea and vomiting. Anaesthesia 2007; 62: 810-817. (Pubitemid 47103631)
9. Gan TJ, Meyer TA, Apfel CC, Chung F, Davis PJ, Habib AS, Hooper VD, Kovac AL, Kranke P, Myles P, Philip BK, Samsa G, Sessler DI, Temo J, Tramèr MR, Vander Kolk C, Watcha M,. Society for Ambulatory Anesthesia guidelines for the management of postoperative nausea and vomiting. Anesth Analg 2007; 105: 1615-1628. (Pubitemid 350190555)
10. Tramèr MR, Reynolds DJ, Moore RA, McQuay HJ,. Efficacy, dose-response, and safety of ondansetron in prevention of postoperative nausea and vomiting: a quantitative systematic review of randomized placebo-controlled trials. Anesthesiology 1997; 87: 1277-1289. (Pubitemid 28007321)
11. Paech MJ, Rucklidge MW, Lain J, Dodd PH, Bennett EJ, Doherty DA,. Ondansetron and dexamethasone dose combinations for prophylaxis against postoperative nausea and vomiting. Anesth Analg 2007; 104: 808-814. (Pubitemid 46548301)
12. Gan TJ,. Risk factors for postoperative nausea and vomiting. Anesth Analg 2006; 102: 1884-1898. (Pubitemid 43799873)
13. Moher D, Schulz KF, Altman D, CONSORT Group. The CONSORT Statement: revised recommendations for improving the quality of reports of parallel-group randomized trials 2001. Explore 2005; 1: 40-45.
14. Meinert CL,. Design, conduct and analysis. In:, Meinert CL, ed. Clinical trials. Oxford, New York: Oxford University Press Inc., 1986: 97-99.
15. Stubhaug A, Breivik H,. Clinical trials: acute and chronic pain. In:, Breivik H, Campbell W, Eccleston C, eds. Clinical pain management: practical applications and procedures. New York: Oxford University Press Inc., 2003: 449-458.
16. Schnaider TB, Vieira AM, Brandão AC,. Comparative study of anti-emetics and their association, in the prevention of postoperative nausea and vomiting in patients undergoing gynecologic surgeries. Rev Bras Anestesiol 2008; 58: 614-622.
17. Kranke P, Eberhart LH,. Postoperative nausea and vomiting: rational algorithms for prevention and treatment based on current evidence. Anasthesiol Intensivmed Notfallmed Schmerzther 2009; 44: 286-294.
18. Romundstad L, Breivik H, Niemi G, Helle A, Stubhaug A,. Methylprednisolone intravenously 1 day after surgery has sustained analgesic and opioid-sparing effects. Acta Anaesthesiol Scand 2004; 48: 1223-1231. (Pubitemid 39490854)
19. Romundstad L, Breivik H, Roald H, Skolleborg K, Haugen T, Narum J, Stubhaug A,. Methylprednisolone reduces pain, emesis, and fatigue after breast augmentation surgery: a single-dose, randomized, parallel-group study with methylprednisolone 125mg, parecoxib 40mg, and placebo. Anesth Analg 2006; 102: 418-425. (Pubitemid 43152589)
20. Rubin GJ, Hotopf M,. Systematic review and meta-analysis of interventions for postoperative fatigue. Br J Surg 2002; 89: 971-984. (Pubitemid 34994688)
21. Hval K, Thagaard KS, Schlichting E, Raeder J,. The prolonged postoperative analgesic effect when dexamethasone is added to a nonsteroidal antiinflammatory drug (rofecoxib) before breast surgery. Anesth Analg 2007; 105: 481-486.
22. Sauerland S, Nagelschmidt M, Mallmann P, Neugebeuer EA,. Risks and benefits of preoperative high dose methylprednisolone in surgical patients: a systematic review. Drug Saf 2000; 23: 449-461.
23. Holte K, Kehlet H,. Perioperative single-dose glucocorticoid administration: pathophysiologic effects and clinical implications. J Am Coll Surg 2002; 195: 694-712. (Pubitemid 35285405)
24. Czarnetzki C, Elia N, Lysakowski C, Dumont L, Landis BN, Giger R, Dulguerov P, Desmeules J, Tramèr MR,. Dexamethasone and risk of nausea and vomiting and postoperative bleeding after tonsillectomy in children: a randomized trial. JAMA 2008; 300: 2621-2630.
25. Sam TS, Chan SW, Rudd JA, Yeung JH,. Action of glucocorticoids to antagonise cisplatin-induced acute and delayed emesis in the ferret. Eur J Pharmacol 2001; 417: 231-237. (Pubitemid 32385771)
26. Suzuki T, Sugimoto M, Koyama H, Mashimo T, Uchida I,. Inhibitory effect of glucocorticoids on human-cloned 5-hydroxytryptamine3A receptor expressed in xenopus oocytes. Anesthesiology 2004; 10: 660-665. (Pubitemid 39121645)
27. Ho CM, Ho ST, Wang JJ, Tsai SK, Chai CY,. Dexamethasone has a central antiemetic mechanism in decerebrated cats. Anesth Analg 2004; 99: 734-739.
28. Di S, Malcher-Lopes R, Halmos KC, Tasker JG,. Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 2003; 23: 4850-4857. (Pubitemid 36793211)
29. Izzo AA, Coutts AA,. Cannabinoids and the digestive tract. Handb Exp Pharmacol 2005; 168: 573-598.